Pharmaceutical firms donate an enormous amount of their products (and some cash too). But it doesn’t seem to be helping their reputation. We ask Pfizer’s generosity chief why the company gives so much, who it really helps, and whether all this philanthropy is just corporate whitewashing.
Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)
You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.
Stay up-to-date on all our shows. We promise no spam.
